Yang M, Zhang D, Yuan Z, Chen D, Ju H, Wu B
NPJ Precis Oncol. 2025; 9(1):75.
PMID: 40089605
DOI: 10.1038/s41698-025-00864-2.
Olazabal-Herrero A, He B, Kwon Y, Gupta A, Dutta A, Huang Y
Cell Rep. 2024; 43(1):113610.
PMID: 38165804
PMC: 10865995.
DOI: 10.1016/j.celrep.2023.113610.
Xia D, Zhu X, Wang Y, Gong P, Su H, Xu X
Biosci Rep. 2023; 43(10).
PMID: 37728310
PMC: 10550789.
DOI: 10.1042/BSR20222591.
Xu N, Cui Y, Shi H, Guo G, Sun F, Jian T
Invest Ophthalmol Vis Sci. 2022; 63(9):20.
PMID: 35980647
PMC: 9404369.
DOI: 10.1167/iovs.63.9.20.
Zhang J, Wang J, Wu J, Huang J, Lin Z, Lin X
Oncol Rep. 2022; 48(2).
PMID: 35703356
PMC: 9245069.
DOI: 10.3892/or.2022.8350.
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
Wang X, Liu Y, Leng X, Cao K, Sun W, Zhu J
Pathol Oncol Res. 2021; 27:632531.
PMID: 34257599
PMC: 8262217.
DOI: 10.3389/pore.2021.632531.
Structure of the FA core ubiquitin ligase closing the ID clamp on DNA.
Wang S, Wang R, Peralta C, Yaseen A, Pavletich N
Nat Struct Mol Biol. 2021; 28(3):300-309.
PMID: 33686268
PMC: 8378520.
DOI: 10.1038/s41594-021-00568-8.
The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
Ho N, Leung C, Wong T, Lau E, Lei M, Mok E
Cell Death Dis. 2021; 12(2):148.
PMID: 33542213
PMC: 7862307.
DOI: 10.1038/s41419-021-03403-6.
A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination.
Yu Z, Jiang X, Qin L, Deng H, Wang J, Ren W
Oncogene. 2020; 40(5):1027-1042.
PMID: 33323973
PMC: 7862066.
DOI: 10.1038/s41388-020-01572-w.
Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X, Liu G, Liu R, He J, Wang G, Zhang H
Oncol Lett. 2020; 20(5):275.
PMID: 33014154
PMC: 7520753.
DOI: 10.3892/ol.2020.12138.
Structural insight into FANCI-FANCD2 monoubiquitination.
Li L, Tan W, Deans A
Essays Biochem. 2020; 64(5):807-817.
PMID: 32725171
PMC: 7588663.
DOI: 10.1042/EBC20200001.
Differential functions of FANCI and FANCD2 ubiquitination stabilize ID2 complex on DNA.
Rennie M, Lemonidis K, Arkinson C, Chaugule V, Clarke M, Streetley J
EMBO Rep. 2020; 21(7):e50133.
PMID: 32510829
PMC: 7332966.
DOI: 10.15252/embr.202050133.
Characterization of FANCL variants observed in patient cancer cells.
Frost M, Mazloumi Aboukheili A, Toth R, Walden H
Biosci Rep. 2020; 40(6).
PMID: 32420600
PMC: 7273913.
DOI: 10.1042/BSR20191304.
Fanconi anemia pathway as a prospective target for cancer intervention.
Liu W, Palovcak A, Li F, Zafar A, Yuan F, Zhang Y
Cell Biosci. 2020; 10:39.
PMID: 32190289
PMC: 7075017.
DOI: 10.1186/s13578-020-00401-7.
Monoubiquitination by the human Fanconi anemia core complex clamps FANCI:FANCD2 on DNA in filamentous arrays.
Tan W, van Twest S, Leis A, Bythell-Douglas R, Murphy V, Sharp M
Elife. 2020; 9.
PMID: 32167469
PMC: 7156235.
DOI: 10.7554/eLife.54128.
ATR-Mediated FANCI Phosphorylation Regulates Both Ubiquitination and Deubiquitination of FANCD2.
Tan W, van Twest S, Murphy V, Deans A
Front Cell Dev Biol. 2020; 8:2.
PMID: 32117957
PMC: 7010609.
DOI: 10.3389/fcell.2020.00002.
A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2.
Dubois E, Guitton-Sert L, Beliveau M, Parmar K, Chagraoui J, Vignard J
Nucleic Acids Res. 2019; 47(14):7532-7547.
PMID: 31219578
PMC: 6698648.
DOI: 10.1093/nar/gkz514.
Deficiency of the Fanconi anemia E2 ubiqitin conjugase UBE2T only partially abrogates Alu-mediated recombination in a new model of homology dependent recombination.
Lewis T, Barthelemy J, Virts E, Kennedy F, Gadgil R, Wiek C
Nucleic Acids Res. 2019; 47(7):3503-3520.
PMID: 30715513
PMC: 6468168.
DOI: 10.1093/nar/gkz026.
Binding of FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2 Monoubiquitination.
Liang Z, Liang F, Teng Y, Chen X, Liu J, Longerich S
Cell Rep. 2019; 26(3):564-572.e5.
PMID: 30650351
PMC: 6350941.
DOI: 10.1016/j.celrep.2018.12.084.
UBE2T knockdown inhibits gastric cancer progression.
Luo C, Yao Y, Yu Z, Zhou H, Guo L, Zhang J
Oncotarget. 2017; 8(20):32639-32654.
PMID: 28427240
PMC: 5464816.
DOI: 10.18632/oncotarget.15947.